US Renal Data System. Minneapolis, MN: US Renal Data System. Available at
US Renal Data System. Renal Data Extraction and Referencing (RenDER) System. Minneapolis, MN: US Renal Data System; 2014. Available at http://www.usrds.org.
US Renal Data System. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available at
US Renal Data System. USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013. Available at http://www.usrds.org/atlas.aspx.
Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline
Burrows NR, Li Y, Geiss LS. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care 2010;33:73-7.
In: Venkat Narayan KM, Williams D, Gregg EW, Cowie C, eds. New York, NY: Oxford University Press
Pavkov ME, Burrows NR, Knowler WC, Hanson RL, Nelson RG. Diabetes and chronic kidney disease. In: Venkat Narayan KM, Williams D, Gregg EW, Cowie C, eds. Diabetes public health: from data to policy. New York, NY: Oxford University Press; 2011:135-60.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33
UK Prospective Diabetes Study Group
UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. Lancet 1998;352:837-53.
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
UK Prospective Diabetes Study Group
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-13.